Baker IDI Heart and Diabetes Institute:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Baker IDI Heart and Diabetes Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9359
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Baker IDI Heart and Diabetes Institute (Baker Institute) is a medical research organization that offers diagnosis, prevention, treatment of diabetics and cardiovascular disease. The organization offers clinical services such as diabetes services, weight assessment and management clinic healthy hearts clinic, among others. Its research programs include cellular and molecular biology, diabetic complications, hypertension and cardiac disease, atherothrombosis and metabolism. Baker Institute’s health hub provides education and training, clinics, books, events for public and health professionals, and health matter talks. The institute has partnerships and collaborations with other clinical research centers. Baker Institute is headquartered in Melbourne, Victoria, Australia.

Baker IDI Heart and Diabetes Institute – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Baker IDI Heart and Diabetes Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Baker IDI Heart and Diabetes Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Baker IDI Heart and Diabetes Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Baker IDI Heart and Diabetes Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Baker IDI Heart and Diabetes Institute, Medical Devices Deals, 2012 to YTD 2018 9
Baker IDI Heart and Diabetes Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Baker IDI Heart and Diabetes Institute, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
Crescent Capital Partners Acquires Nucleus Network from Baker Institute 11
Partnerships 12
Imugene Enters into Agreement with Baker IDI Heart & Diabetes Institute 12
AdAlta Enters into Agreement with Baker Institute 13
Baker IDI Heart and Diabetes Institute – Key Competitors 14
Baker IDI Heart and Diabetes Institute – Key Employees 15
Baker IDI Heart and Diabetes Institute – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Government and Public Interest 17
Nov 01, 2018: Dangerous blood pressure caused by specific signalling in the brain 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Baker IDI Heart and Diabetes Institute, Pharmaceuticals & Healthcare, Key Facts 2
Baker IDI Heart and Diabetes Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Baker IDI Heart and Diabetes Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Baker IDI Heart and Diabetes Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Baker IDI Heart and Diabetes Institute, Deals By Therapy Area, 2012 to YTD 2018 8
Baker IDI Heart and Diabetes Institute, Medical Devices Deals, 2012 to YTD 2018 9
Baker IDI Heart and Diabetes Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Crescent Capital Partners Acquires Nucleus Network from Baker Institute 11
Imugene Enters into Agreement with Baker IDI Heart & Diabetes Institute 12
AdAlta Enters into Agreement with Baker Institute 13
Baker IDI Heart and Diabetes Institute, Key Competitors 14
Baker IDI Heart and Diabetes Institute, Key Employees 15
Baker IDI Heart and Diabetes Institute, Other Locations 16

List of Figures
Baker IDI Heart and Diabetes Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Baker IDI Heart and Diabetes Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Baker IDI Heart and Diabetes Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Baker IDI Heart and Diabetes Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Baker IDI Heart and Diabetes Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Baker IDI Heart and Diabetes Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Baker IDI Heart and Diabetes Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Baker IDI Heart and Diabetes Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Baker IDI Heart and Diabetes Institute, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Baker IDI Heart and Diabetes Institute:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NorthWestern Corporation:企業の戦略・SWOT・財務分析
    NorthWestern Corporation - Strategy, SWOT and Corporate Finance Report Summary NorthWestern Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Merck KGaA (MRK):企業の財務・戦略的SWOT分析
    Merck KGaA (MRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • TeaM Energy Corp:企業の戦略的SWOT分析
    TeaM Energy Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Almac Discovery Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Almac Discovery Ltd (Almac Discovery), a subsidiary of Almac Group Ltd is a healthcare service provider that discovers and develops drugs for the treatment of cancer. The company develops drugs, small molecule and therapeutic peptide, biomarkers and diagnostic tools. It provides early drug d …
  • Greatship (India) Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Greatship (India) Ltd (GIL), a subsidiary of The Great Eastern Shipping Co. Ltd is an offshore oilfield service provider that offers shipping and transportation services. The company transports crude oil, petroleum products, gas and bulk commodities. It provides offshore logistics and drilli …
  • Vision RT Ltd:企業の戦略的SWOT分析
    Vision RT Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Cleveland-Cliffs Inc:企業の戦略・SWOT・財務分析
    Cleveland-Cliffs Inc - Strategy, SWOT and Corporate Finance Report Summary Cleveland-Cliffs Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Murray & Roberts Holdings Ltd (MUR):企業の財務・戦略的SWOT分析
    Murray & Roberts Holdings Ltd (MUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Nanomix Inc:医療機器:M&Aディール及び事業提携情報
    Summary Nanomix Inc (Nanomix) is a medical device company that develops analytical detection devices for the point of care diagnostics. The company provides Nanomix system, which is an automated system consisting of a handheld reader and self-contained assay cartridge with a carbon nanotube biosenso …
  • Longfor Group Holdings Limited:企業の戦略・SWOT・財務情報
    Longfor Group Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Longfor Group Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • VeriSign Inc (VRSN):企業の財務・戦略的SWOT分析
    VeriSign Inc (VRSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • The Tata Power Company Limited:企業の戦略・SWOT・財務分析
    The Tata Power Company Limited - Strategy, SWOT and Corporate Finance Report Summary The Tata Power Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Equinix Inc (EQIX):企業の財務・戦略的SWOT分析
    Equinix Inc (EQIX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Spectrum Health System:企業の戦略的SWOT分析
    Spectrum Health System - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Altin Yunus Cesme Turistik Tesisler A.S.:企業の戦略・SWOT・財務情報
    Altin Yunus Cesme Turistik Tesisler A.S. - Strategy, SWOT and Corporate Finance Report Summary Altin Yunus Cesme Turistik Tesisler A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • KPIT Technologies Ltd (BSOFT):企業の財務・戦略的SWOT分析
    KPIT Technologies Ltd (BSOFT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Alon USA Energy Inc (ALJ)-石油・ガス分野:企業M&A・提携分析
    Summary Alon USA Energy Inc (Alon USA), a subsdiary of Delek US Holdings, Inc., is a refiner and marketer of petroleum products. The products offered by the company include various grades of gasoline, diesel fuel, jet fuel, petrochemicals, petrochemical feedstocks, asphalt, and other petroleum-based …
  • Braskem SA (BRKM5):企業の財務・戦略的SWOT分析
    Braskem SA (BRKM5) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Toho Gas Co Ltd (9533):企業の財務・戦略的SWOT分析
    Toho Gas Co Ltd (9533) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Forterra, Inc. (FRTA):企業の財務・戦略的SWOT分析
    Forterra, Inc. (FRTA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆